Drugs / 5-chloro-2,4-dihydropyridine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00197431 Background | Jan 2004 → ? | colon carcinoma, esophageal cancer, gastric cancer, malignant pancreatic neoplasm | Hamamatsu University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-chloro-2,4-dihydropyridine | “5-chloro-2,4-dihydropyridine (CDHP), which inhibits dihydropyrimidine dehydrogenase (DPD) activity;” NCT00197431 ↗ |
| Known as | CDHP | “5-chloro-2,4-dihydropyridine (CDHP), which inhibits dihydropyrimidine dehydrogenase (DPD) activity;” NCT00197431 ↗ |
| Action | Inhibit | “inhibits dihydropyrimidine dehydrogenase (DPD) activity” NCT00197431 ↗ |